Evolution of the Average Target: RH

Evolution of the Average Target - RH

Evolution of the Target Price: RH

Evolution of the Target Price - RH

Changes in Analyst Recommendations: RH

8fc573587560.a0bKL6iIpc7wieOsjPCsX3NAzEinxYr96UEzc4qVSuA.JnCjGcnA0ZyY4qHW4rT5BQAqiCzf9OaLonNFFrzlLqQbCvIcmubomKm4ug~4450452c6941df2a5e91c4118f41028a
Sep. 11 UBS Adjusts Price Target on RH to $154 From $155, Keeps Neutral Rating MT
Sep. 11 BofA Securities Adjusts RH Price Target to $114 From $156, Maintains Underperform Rating MT
Jul. 08 Goldman Sachs Upgrades RH to Neutral From Sell, Lifts Price Target to $155 From $86 MT
Jun. 09 RH Q1 Unlikely to Show Business Inflection, UBS Says MT
Jun. 09 UBS Adjusts Price Target on RH to $155 From $160, Maintains Neutral Rating MT
Apr. 01 Guggenheim Lowers Price Target on RH to $200 From $275, Keeps Buy Rating MT
Apr. 01 RH Facing Near-Term Challenges From Execution, Supply Chain Issues, Morgan Stanley Says MT
Apr. 01 Morgan Stanley Lowers Price Target on RH to $240 From $275, Keeps Overweight Rating MT
Dec. 19 JPMorgan Cuts Price Target on RH to $225 From $275, Maintains Overweight Rating MT
Dec. 12 Stifel Downgrades RH to Hold From Buy, Adjusts Price Target to $165 From $320 MT
25-10-02 William Blair Downgrades RH to Market Perform From Outperform MT
25-09-12 Telsey Advisory Downgrades RH to Market Perform From Outperform, Adjusts Pt to $220 From $255 MT
25-06-24 RH Shares Fall After Goldman Sachs Downgrade MT
25-06-24 Goldman Sachs Downgrades RH to Sell From Neutral, Adjusts Price Target to $179 From $199 MT
25-06-05 UBS Adjusts RH Price Target to $215 From $235, Maintains Neutral Rating MT
25-05-14 BofA Securities Adjusts Price Target on RH to $172 From $144 MT
25-04-07 RH Cash Flow, Demand Guidance Eases Tariff Concerns, Wedbush Says MT
25-04-03 RH Earnings Troubles Exacerbated by Trump Tariffs, Wedbush Says; Shares Down Pre-Bell MT
25-04-03 Wedbush Adjusts RH Price Target to $250 From $350, Maintains Outperform Rating MT
25-04-03 UBS Adjusts Price Target on RH to $235 From $250, Keeps Neutral Rating MT
25-03-26 RH Could See Solid Sales, Soft Margins for Fiscal Q4, Wedbush Says MT
25-03-26 BofA Securities Cuts RH Price Target to $410 From $510, Maintains Buy Rating MT
25-03-26 Wedbush Cuts Price Target on RH to $350 From $500, Keeps Outperform Rating MT
25-03-21 UBS Adjusts Price Target on RH to $250 From $440, Keeps Neutral Rating MT
25-01-30 Goldman Sachs Upgrades RH to Neutral From Sell, Raises Price Target to $374 From $261 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+41.66%
+3.67%
-6.77%
+17.81%
+9.87%
+7.8%
+20.18%
+27.92%
+8.78%
+1.83%
Average +13.27%
Weighted average by Cap. +4.80%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
115.60USD
Average target price
163.76USD
Spread / Average Target
+41.66%
High Price Target
258.00USD
Spread / Highest target
+123.18%
Low Price Target
81.00USD
Spread / Lowest Target
-29.93%

Analyst Consensus Detail

Analyst consensus - RH

Consensus revision (last 18 months)

Consensus revision (last 18 months) - RH
Trader
Investor
Global
Quality
-
ESG MSCI
BB
MarketScreener Ratings - RH